Literature DB >> 10820725

Phage libraries for generation of anti-botulinum scFv antibodies.

P Amersdorfer1, J D Marks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820725     DOI: 10.1385/1-59259-052-7:219

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


× No keyword cloud information.
  5 in total

1.  Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.

Authors:  Sean A Gray; John R Barr; Suzanne R Kalb; James D Marks; Cheryl L Baird; Gerard A Cangelosi; Keith D Miller; Michael J Feldhaus
Journal:  Biotechnol Bioeng       Date:  2011-05-12       Impact factor: 4.530

2.  Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; Stephen T Keir; Jianjun Li; James E Herndon; Ira Pastan; Darell D Bigner
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

3.  Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach.

Authors:  Michael B Kuepper; Michael Huhn; Holger Spiegel; Julian K C Ma; Stefan Barth; Rainer Fischer; Ricarda Finnern
Journal:  BMC Biotechnol       Date:  2005-01-25       Impact factor: 2.563

4.  Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.

Authors:  Chien-Tsun Kuan; Nidhi Srivastava; Roger E McLendon; Wayne A Marasco; Michael R Zalutsky; Darell D Bigner
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

Review 5.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.